Home/Filings/4/0001415889-25-006986
4//SEC Filing

Marban Linda 4

Accession 0001415889-25-006986

CIK 0001133869other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:00 PM ET

Size

9.1 KB

Accession

0001415889-25-006986

Insider Transaction Report

Form 4
Period: 2025-03-03
Marban Linda
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-03$1.39/sh+25,000$34,750223,604 total
  • Other

    Common Stock

    2025-03-0512,500211,104 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-03-0325,0000 total
    Exercise: $1.39Exp: 2025-03-03Common Stock (25,000 underlying)
Footnotes (3)
  • [F1]Transferred to reporting person's ex-spouse pursuant to settlement in divorce proceeding.
  • [F2]This option was granted on March 3, 2015 and was previously covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
  • [F3]Shares vested 1/48th on the first day of each month commencing April 1, 2015.

Issuer

CAPRICOR THERAPEUTICS, INC.

CIK 0001133869

Entity typeother

Related Parties

1
  • filerCIK 0001593084

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:00 PM ET
Size
9.1 KB